antimicrobial resistance - cddep
TRANSCRIPT
![Page 1: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/1.jpg)
Antimicrobial Resistance
Ramanan LaxminarayanSingapore International Infectious Disease Conference 2017
![Page 2: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/2.jpg)
Inthebeginning…
![Page 3: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/3.jpg)
Cyanobacteriareleaseoxygenintotheatmosphereviaphotosynthesispavingthewayformorecomplexlifeforms
![Page 4: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/4.jpg)
Dinosaursappears265millionyearsago
Dinosaurs
![Page 5: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/5.jpg)
Hominidsarrivedafewmillionyearsago
Earliest hominids
![Page 6: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/6.jpg)
Lifedependsonmicrobes
• Microbesoutnumberallotherspeciesandmakeupmostlivingmatter(~60%oftheearthsbiomass).
• Lessthan0.5%oftheestimated2to3billionmicrobialspecieshavebeenidentified.
• Microbesgeneratehalftheoxygenthatwebreathe
![Page 7: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/7.jpg)
MicrobeswerealsothecauseofdeathAll causes (United States, 1900) 1548.4
11- Tuberculosis2- Pneumonia and influenza3- Heart disease4- Diarrhea, enteritis, ulcers5-Intrachrania lesions – vascular6- Nephritis7- Accidents excluding automobile8- Cancer 9- Senility10- Bronchitis
174.2161.3145.4104.9103.990.672.566.345.239.4
CDC/NCHS – National Vital Statistics Mortality vol48
![Page 8: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/8.jpg)
ButnolongerAll causes (United States, 2000)19
864.7
1- Heart Disease2 - Malignant neoplasm's (cancer)3 - Cerebrovascular diseases4- COPD5- Accidents Automobile/Others6- Pneumonia and influenza7- Diabetes mellitus8- Suicide 9 - Nephritis10- Chronic Liver Disease
268.2200.358.641.716.1/2034.024.011.39.7CDC/NCHS – National Vital Statistics Mortality vol48
![Page 9: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/9.jpg)
DeathRatesforCommonInfectiousDiseasesintheUnitedStates(per100,000Population) 1900 1935 1970
Influenza and Pneumonia 202.2 104 31
Tuberculosis 194.4 55 3
Gastroenteritis 142.7 14 1
Diphtheria 40.3 3 0
Typhoid fever 31.3 3 0
Measles 13.3 3 0
Dysentery 12 2 0
Whooping Cough 12 4 0
Scarlet fever (including strep throat) 9.6 2 0
Meningococcal infections 6.8 2 0
![Page 10: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/10.jpg)
Bassett et al, Science, 1980
![Page 11: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/11.jpg)
Alexander Fleming1881-1955
![Page 12: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/12.jpg)
When I woke up just after dawn on September 28, 1928, I certainly didn't plan to revolutionise all medicine by discovering the world's first antibiotic, or bacteria killer. But I suppose that was exactly what I did.
— Alexander Fleming
![Page 13: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/13.jpg)
![Page 14: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/14.jpg)
![Page 15: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/15.jpg)
![Page 16: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/16.jpg)
Alexander Fleming1881-1955
Giuseppe Brotzu1895-1976
![Page 17: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/17.jpg)
![Page 18: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/18.jpg)
Cephalosporium acremonium
![Page 19: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/19.jpg)
![Page 20: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/20.jpg)
Mortalityratesofpatientswithbacteremicpneumococcalpneumonia
Treatment No. % mortalitySymptomatic1 356 80Penicillin1 (1940s) 333 17
1M. Finland. Clinical Pharmacology and Therapeutics 13:469-511, 1972.
![Page 21: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/21.jpg)
I. Drugresistanceisrisingworldwideandthreatensgainsmadeinreducingtheburdenofinfectiousdiseases
![Page 22: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/22.jpg)
![Page 23: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/23.jpg)
![Page 24: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/24.jpg)
D’Costa,Nature,2011
![Page 25: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/25.jpg)
![Page 26: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/26.jpg)
![Page 27: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/27.jpg)
![Page 28: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/28.jpg)
![Page 29: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/29.jpg)
![Page 30: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/30.jpg)
![Page 31: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/31.jpg)
![Page 32: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/32.jpg)
![Page 33: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/33.jpg)
Woerther,Clin Microbiol Rev.2013
ESBLcarriageratesareincreasingovertime
![Page 34: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/34.jpg)
![Page 35: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/35.jpg)
![Page 36: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/36.jpg)
36
ClonalspreadofS.pneumoniae 23F
Tennessee
Cleveland
Mexico
Colombia
Brazil
ArgentinaUruguay
Chile SouthAfrica
SingaporeMalaysia
ThailandPhilippines
HongKongTaiwan
SouthKoreaSpain
FranceBM42001978?
Finland
Slidecourtesy:KeithKlugman
![Page 37: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/37.jpg)
Numbersofuniqueβ-lactamaseenzymesidentifiedsinceintroductionoffirstβ-lactamantibiotics
DaviesandDavies,Microbiol.Mol.Biol.Rev.2010.
![Page 38: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/38.jpg)
Mortalityoutcomesareworseinneonateswithresistantinfections
Kayange M,Kamugisha E,Mwizamholya DL,JeremiahS,Mshana SE.2010.Predictorsofpositivebloodcultureanddeathsamongneonateswithsuspectedneonatalsepsisinatertiaryhospital,Mwanza- Tanzania.BMCPediatrics10:39.
149
58
369
151
91
5523
0
10
20
30
40
50
60
Culture GramReaction ESBL MRSA
Death(%
)
Parameter
Positive
Negative
![Page 39: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/39.jpg)
DeNIS Study,LancetID,2016
![Page 40: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/40.jpg)
![Page 41: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/41.jpg)
LaxminarayanetalLancet,2015
![Page 42: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/42.jpg)
![Page 43: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/43.jpg)
Absolute risk reduction (ARR) of infection with antibiotic prophylaxis in common surgical procedures and blood cancer chemotherapy in the
USA
Teillant etal,LancetInfectDis,2015
![Page 44: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/44.jpg)
Number of additional infections per year in the USA under a 30% decreased efficacy of antibiotic prophylaxis
Teillant etal,LancetInfectDis,2015
![Page 45: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/45.jpg)
Surgicalsiteinfections
• Thereare92millionsurgeriesinlow-incomecountrieseachyear• 5.5millionsurgicalsiteinfectionsorSSIs(6per100procedures)–aboutathirdofallhealthcareassociatedinfections
• SSIsaretheleadingcauseofinfectioninsettingswithlimitedresources
• MortalityratefromSSIRatesofmortalityfromsurgicalsiteinfectionsare3%intheUSandbetween8and20%inlow-incomecountries
• Between400,000andamilliondeathsfromSSIseachyearwithanincreasingnumbercausedbyresistantpathogens.
![Page 46: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/46.jpg)
Lahra etal,MicrobiologyAustralia,Nov2016
![Page 47: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/47.jpg)
II. Risingincomesandincreasingaccesstoantibioticsaresavinglives(althoughlackofaccessstillkillsmorepeoplethanantibioticresistance)butarenotagoodsubstituteforpublichealth
![Page 48: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/48.jpg)
Bacterialdiseasesarestillmajorkillersindevelopingcountriesbecauseoflackofaccesstoantibiotics
O’Brienetal,Lancet2009
![Page 49: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/49.jpg)
Pneumococcalpneumoniadeathsavertablewithimprovedantibioticaccess
Laxminarayanetal,Lancet,2015
![Page 50: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/50.jpg)
Whatareweaskingofantibiotics?
![Page 51: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/51.jpg)
Substituteforimmunization,infectioncontrolandwater/sanitation
South Asia
![Page 52: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/52.jpg)
Substituteforimmunization,infectioncontrolandwater/sanitation
Sub-Saharan Africa
![Page 53: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/53.jpg)
Population without access to improved sanitation, by MDG region 2012
Source: WHO/UNICEF 2014
![Page 54: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/54.jpg)
Kyaw MH et al. N Engl J Med 2006;354:1455-1463.
VaccinescanbeeffectiveInvasivediseasecausedbyPneumococciinchildrenundertwodeclinedintheUSpostpneumovaccination
![Page 55: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/55.jpg)
EffectofPCV7introductionin2000onantibioticprescriptionsandambulatorycarevisits
Zhou et al, Pediatrics 2008
![Page 56: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/56.jpg)
EffectofPCV7introductionin2000onantibioticprescriptionsandambulatorycarevisits
Zhou et al, Pediatrics 2008
Antibiotic prescriptions attributable to acute otitis media decreased from 1244 to 722 prescriptions per 1000 person-years – a 41.9% reduction.
![Page 57: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/57.jpg)
LaxminarayanetalLancet,2015
![Page 58: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/58.jpg)
Antibiotic consumption is increasing in developing countries...
Source: Based on data obtained under license from IMS Health MIDAS ™ (January 2005-December 2010); IMS Health Incorporated. All Rights Reserved.
0
5000
10000
15000
20000
25000
BRAZIL, RETAIL INDIA, RETAIL VIETNAM, RETAIL NORWAY, RETAIL USA, RETAIL
Stan
dard
Uni
ts pe
r 100
0 po
pula
tion
Per capita total antibiotic use, retail sector, 2005-2010
2005
2006
2007
2008
2009
2010
![Page 59: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/59.jpg)
![Page 60: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/60.jpg)
-50 – -30 -29 – -20 -19 – -10 -9 – 0 1 – 10 11 – 20 21 – 40 41 – 80 >80 No data
Percentage change in antibiotic consumption per capita 2000–2010*, by country
Source: Van Boeckel et al. 2015 (adapted; based on IMS MIDAS)
*Data for Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama were available only as a group classified as Central America. Similarly, data for Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Gabon, Guinea, Mali, Republic of the Congo, Senegal, and Togo were grouped and classified as French West Africa. The data for these countries represent the estimates for the corresponding regional groupings they belong to. For countries that did not have data available for 2000, the values for the earliest years for which data were available after 2000 were used to calculate the percentage changes. These countries and initial years are Algeria (2002), Bangladesh (2007), Croatia (2005), Netherlands (2005), and Vietnam (2005).
![Page 61: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/61.jpg)
Total antibiotic consumption in selected countries, 2000 and 2010
Van Boeckel et al. 2014 (based on IMS MIDAS)
![Page 62: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/62.jpg)
![Page 63: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/63.jpg)
Antibiotic use per capita by income in selected countries, 2010
Source: Van Boeckel et al. 2014 (based on IMS MIDAS) and World Bank 2015
![Page 64: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/64.jpg)
Carbapenem retail sales in selected countries, 2005–2010 (per 1,000 population)
Source: Laxminarayan et al. 2013 (based on IMS MIDAS)
*An IMS grouping of Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Gabon, Guinea, Mali, Republic of the Congo, Senegal, and Togo
![Page 65: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/65.jpg)
Faropenem consumptionhasincreasedby154%sinceitwasapprovedforuseinIndiain2010
Gandra etal,Clin Inf Dis,2016
![Page 66: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/66.jpg)
Carbapenem consumption in the hospital sector in selected European countries, 1997–2013
ESAC-Net 2015
![Page 67: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/67.jpg)
Non-prescriptionuseofantimicrobialsiscommon
Morganetal,LancetID,2011
![Page 68: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/68.jpg)
![Page 69: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/69.jpg)
![Page 70: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/70.jpg)
Van Boeckel et al, Lancet Inf Dis, 2014
Thefluseasonisakeydriverofantibioticconsumption
![Page 71: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/71.jpg)
InfluenzaintheUnitedStatesisnearlyperfectlypredictedbyantibioticsalesdata
Polgreen etalInf Cont Hosp Epi,2011
![Page 72: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/72.jpg)
Hospital use of carbapenems is rapidly growing
0
10
20
30
40
50
60
70
VIETNAM, HOSPITAL CHINA, HOSPITAL NORWAY, HOSPITAL USA, HOSPITAL
Stand
ard
Units
per
100
0 po
pula
tion
Per capita total carbapenem use, hospital sector, 2005-2010
2005
2006
2007
2008
2009
2010
Source: Based on data obtained under license from IMS Health MIDAS ™ (January 1999-December 2010); IMS Health Incorporated. All Rights Reserved.
![Page 73: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/73.jpg)
Globalavailabilityofcolistin
Wertheim et al, JGAR 2013
![Page 74: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/74.jpg)
![Page 75: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/75.jpg)
![Page 76: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/76.jpg)
III. Driversofantibioticuserelatetoincentivesandbehaviorofpatients,physicians,pharma,payersandhealthcareinstitutions.
![Page 77: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/77.jpg)
IncentivesforPhysicians
• Satisfyingpatientexpectations
![Page 78: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/78.jpg)
Dosh,JFamPr1999
![Page 79: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/79.jpg)
Decisionfatigueincreasesinappropriateprescribing
Linderetal,JAMAIM,2014
Relativetothefirsthourofasession,theadjustedoddsratiosofantibioticprescribinginthefourthhourwas1.26(95%CI,1.13–1.41)
![Page 80: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/80.jpg)
HospitalIncentives
•Antibioticsareasubstituteforinfectioncontrol
• Infectioncontrolisoftennotcompensated
![Page 81: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/81.jpg)
WhatproportionofhospitalizedpatientsintheUnitedStatesareadministeredanantimicrobial?
A. 25%B. 40%C. 55%D. 70%
![Page 82: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/82.jpg)
WhatproportionofhospitalizedpatientsintheUnitedStatesareadministeredanantimicrobial?
A. 25%B. 40%C. 55%D. 70%
![Page 83: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/83.jpg)
Comparedwithabsenceofcomplications,complicationswereassociatedwitha$39017 highercontributionmarginperpatientwithprivateinsurance($55953vs $16936)anda$1749highercontributionmarginperpatientwithMedicare($3629vs $1880).
![Page 84: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/84.jpg)
![Page 85: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/85.jpg)
• At the start of therapy, 220 (30%) patients were afebrile and had normal white blood cell counts.
• Appropriate cultures were collected from 432 (59%) patients, and 250 (58%) were negative.
• By the 5th day of therapy, 12.5% of empirical antimicrobials were escalated, 21.5% were narrowed or discontinued, and 66.4% were unchanged.
• Narrowing or discontinuation was more likely when cultures were collected at the start of therapy and no infection was noted on an initial radiological study.
![Page 86: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/86.jpg)
![Page 87: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/87.jpg)
![Page 88: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/88.jpg)
IV. Antibioticuseinanimalsectorisincreasinggloballyinresponsetothetremendousgrowthindemandforanimalprotein.
Meanwhileantibioticmanufacturingisexpeditingtheaccumulationofresistancegenesintheenvironment.
![Page 89: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/89.jpg)
![Page 90: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/90.jpg)
Antibioticuseforgrowthpromotionanddiseaseprevention
![Page 91: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/91.jpg)
2/3rds ofthetonnageofantibioticssoldworldwideareusedinagriculture
![Page 92: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/92.jpg)
![Page 93: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/93.jpg)
DemandforpoultryinIndiaandChinaissettoincreasetwotosevenfoldbetween2000and2030
FAO, 2011
![Page 94: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/94.jpg)
Growthindemandforpoultrymeatfrom2000to2030inAsia
![Page 95: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/95.jpg)
GilbertM,ConcheddaG,VanBoeckelTP,CinardiG,LinardC,etal.(2015)IncomeDisparitiesandtheGlobalDistributionofIntensivelyFarmedChickenandPigs.PLOSONE10(7):e0133381.https://doi.org/10.1371/journal.pone.0133381http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0133381
Productivity(kgofmeatperanimalperyear)asafunctionofGDPpercapita
![Page 96: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/96.jpg)
![Page 97: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/97.jpg)
![Page 98: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/98.jpg)
• TotalconsumptioninChina- 92700tonsin2013,
• 54000tonsofantibioticsexcretedbyhumanandanimals- muchofthisenteredintothereceivingenvironmentfollowingvariouswastewatertreatmentsinto58riverbasinsofChina
Zhangetal,Env Sci Tech,2015
![Page 99: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/99.jpg)
High-capacityquantitativePCRarraysdetected149uniqueresistancegenesamongallofthefarmsamples,thetop63ARGsbeingenriched192-fold(median)upto28,000-fold(maximum)comparedwiththeirrespectiveantibiotic-freemanureorsoilcontrols.
![Page 100: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/100.jpg)
FicketalEnv Tox andChem,2009
![Page 101: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/101.jpg)
![Page 102: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/102.jpg)
IncreaseofantibioticresistancegenesamongsoilscollectedatfivesitesinTheNetherlandsfrom1940to2008.
KnappetalEnv Sci Tech,2010
![Page 103: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/103.jpg)
Global antibiotic consumption in livestock (mg per 10 km2 pixels) 2010
Van Boeckel et al., PNAS, 2015
Log10 [(mg/pixel) + 1]
No data0 - 1 4 - 5 5 - 6 6 - 7 7 - 8 8 - 9 9 - 10 10 - 11
![Page 104: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/104.jpg)
Global antibiotic consumption in livestock (mg per 10 km2 pixels) 2010
Van Boeckel et al., PNAS, 2015
Log10 [(mg/pixel) + 1]
No data0 - 1 4 - 5 5 - 6 6 - 7 7 - 8 8 - 9 9 - 10 10 - 11
Globalconsumptionofantimicrobialsinfoodanimalproduction• estimatedat63,151(±1,560)tonnes in2010• projectedtoriseby67%,to105,596(±3,605)tonnes by2030• hotspotslikeIndiawhereareasofhighconsumption(30kgperkm2)for
industrialpoultryproductionareexpectedtogrow312%by2030
![Page 105: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/105.jpg)
Antibiotic consumption in livestock, top ten countries 2010–2030 (projected for 2030)
Van Boeckel et al., PNAS, 2015
![Page 106: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/106.jpg)
V. Isfindingnewantibioticstheanswer?
![Page 107: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/107.jpg)
![Page 108: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/108.jpg)
Therichpaywiththeirwallets,thepoorwiththeirlives
Developed world cost per course of therapyDe
velo
ped
wor
ldDe
velo
ping
wor
ldSupplier
Pfizer
GSK
Ortho-McNeill
Bayer
Roche
Pfizer
Roche
GSK
IDA
Eli Lilly
Oscient
various
Branded product only
Generic product available
Price/full course of therapy
Notes: *Chloramphenicol is not available in developed world—price is therefore estimated. †Ceftriaxone and ciprofloxacin may be available in some tertiary settings in developing world.Source: The Medical Letter (2006), Disease control priorities in developing countries, Lancet (2006), Expert interviews.
$1,500
$1,480
$666.80
$223.30
$16
$11
$5*
$3.60
$103
$39
$121
$145
$144.8
![Page 109: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/109.jpg)
Sulfonamides
Oxazolidinones
Trimethoprim
Streptogramins
Quinolones
Lincosamides
Chloramphenicol
Tetracyclines
Macrolides
Glycopeptides
Aminoglycosides
Penicillins
1930s 1940s 1950s 1960s 1970s 1980s 1990s 2000s
Discoveryofnewclassesofantibiotics
![Page 110: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/110.jpg)
Pipelineofnewanti-microbialdrugsgrowingafteralonglagButpricesarelikelytobehigh
...Is being addressed by large recent reinvestment in novel mechanism development
**
#ofmoleculesinnon-standardanti-microbialclassesinallphasesofdevelopment
#ofmolecules
Year Class of drug
1935194119441945194919501952
19561957195919621968
2000200320052007
SulfonamidesPenicillinsAminoglycosidesCephalosporinsChloramphenicolTetracyclinesMacrolides / Lincosamides /StreptograminsGlycopeptidesRifamycinsNitroimidiazolesQuinolonesTrimethoprim
OxazolidinonesLipopeptidesGlycylcyclinesPleuromutilins
Significant gap in first introduction of new antimicrobial classes...
Source:“BadBugs,NoDrugs”whitepaper,Pharmaprojects,RodmanandRenshaw,NatureReviewsDrugDiscovery,BCGAnalysis
30yeardevelopmentgap
![Page 111: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/111.jpg)
Trendsindevelopmentofnewantibiotics
![Page 112: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/112.jpg)
Trendsindevelopmentofnewantibiotics
Ofthe61newantibioticsapprovedbetween1980and2009,26(43%)werewithdrawneitherbecauseoftoxicityorlackofmarket,comparedwitha13%withdrawalrateforothertherapeuticcategories(Outtersonetal2013)
![Page 113: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/113.jpg)
Laxminarayan, Science, 2014
![Page 114: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/114.jpg)
Laxminarayan, Science, 2014
Incentivesfornewantibiotics,asproposedbyBARDAandEUmayencouragenewdrugdevelopmentbutdon’timpactincentivesforusingdrugsappropriately
![Page 115: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/115.jpg)
ImageCourtesyofShutterstock
• Diagnostics• VaccinesforStaphandGram-negativeinfection
• Bacteriophages• Probiotics• Quorumsensing
![Page 116: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/116.jpg)
![Page 117: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/117.jpg)
![Page 118: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/118.jpg)
![Page 119: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/119.jpg)
![Page 120: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/120.jpg)
![Page 121: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/121.jpg)
ImageCourtesyofShutterstock
![Page 122: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/122.jpg)
Resistancemap.org
![Page 123: Antimicrobial Resistance - CDDEP](https://reader030.vdocuments.us/reader030/viewer/2022020620/61e59139dfbe47362b4c462e/html5/thumbnails/123.jpg)
Slides are downloadable @ www.cddep.org